Ben-Nun A - Search Results

1

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation.

Karussis DM, Slavin S, Ben-Nun A, Ovadia H, Vourka-Karussis U, Lehmann D, Mizrachi-Kol R, Abramsky O. Karussis DM, et al. J Neuroimmunol. 1992 Aug;39(3):201-10. doi: 10.1016/0165-5728(92)90254-i. J Neuroimmunol. 1992. PMID: 1644896

2

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.

Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Ben-Nun A, Kalland T, Abramsky O. Karussis DM, et al. Ann Neurol. 1993 Nov;34(5):654-60. doi: 10.1002/ana.410340506. Ann Neurol. 1993. PMID: 8239559

3

Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis.

Lehmann D, Ben-Nun A. Lehmann D, et al. J Autoimmun. 1992 Dec;5(6):675-90. doi: 10.1016/0896-8411(92)90185-s. J Autoimmun. 1992. PMID: 1489483

4

Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.

Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A. Karussis DM, et al. J Immunol. 1992 Mar 15;148(6):1693-8. J Immunol. 1992. PMID: 1541813

5

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

Karussis DM, Vourka-Karussis U, Lehmann D, Ovadia H, Mizrachi-Koll R, Ben-Nun A, Abramsky O, Slavin S. Karussis DM, et al. J Clin Invest. 1993 Aug;92(2):765-72. doi: 10.1172/JCI116648. J Clin Invest. 1993. PMID: 7688762 Free PMC article.

6

Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).

Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S. Karussis DM, et al. Clin Exp Immunol. 1995 Apr;100(1):111-7. doi: 10.1111/j.1365-2249.1995.tb03611.x. Clin Exp Immunol. 1995. PMID: 7697909 Free PMC article.

7

Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis.

Ben-Nun A, Yossefi S, Lehmann D. Ben-Nun A, et al. Eur J Immunol. 1993 Mar;23(3):689-96. doi: 10.1002/eji.1830230318. Eur J Immunol. 1993. PMID: 8095458

8

Intraperitoneal injection of CD4+ T cells induces CD5 B cells. Implications for a regulatory role of CD5 B cells in experimental autoimmune encephalomyelitis.

Lehmann D, Ben-Nun A. Lehmann D, et al. Ann N Y Acad Sci. 1992 May 4;651:579-80. doi: 10.1111/j.1749-6632.1992.tb24667.x. Ann N Y Acad Sci. 1992. PMID: 1376081 No abstract available.

9

Delineation of tissue damage mechanisms in experimental autoimmune encephalomyelitis (EAE). I. Cell detachment and lysis induced by encephalitogenic CD4+ T lymphocytes.

Halachmi E, Ben-Nun A, Lehmann D, Karussis D, Wekerle H, Berke G. Halachmi E, et al. J Autoimmun. 1992 Aug;5(4):411-25. doi: 10.1016/0896-8411(92)90002-8. J Autoimmun. 1992. PMID: 1384527

10

Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.

Karni A, Bakimer-Kleiner R, Abramsky O, Ben-Nun A. Karni A, et al. Arch Neurol. 1999 Mar;56(3):311-5. doi: 10.1001/archneur.56.3.311. Arch Neurol. 1999. PMID: 10190821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters